Data Monitoring Committees (DMCs), also known as Data and Safety Monitoring Boards (DSMBs) or Independent Data Monitoring Committees (IDMCs), play a crucial role in ensuring the safety of participants and the integrity of clinical trials. DMCs are independent expert committees responsible for monitoring and reviewing clinical trial data during its conduct. Here are some key aspects of the role of DMCs in clinical trials: Safety Monitoring: One of the primary responsibilities of DMCs is to monitor the safety of trial participants. They review and analyze safety data, including adverse events, serious adverse events, and other safety-related information. DMCs assess whether the trial intervention or study procedures pose any unexpected risks to participants and may recommend modifications or discontinuation of the trial if safety concerns arise. Data Integrity and Quality: DMCs ensure the integrity and quality of clinical trial data. They review and assess the overall conduct of the trial, including data collection, data management processes, and adherence to the study protocol. DMCs monitor for potential biases, data errors, and deviations from the protocol that may affect the reliability and validity of trial results. Interim Analysis and Efficacy Monitoring: DMCs conduct periodic interim analyses of the trial data to assess the efficacy of the intervention. These analyses help evaluate whether the trial should continue as planned or if early termination or modifications are warranted based on the evidence of treatment efficacy or futility. DMCs use pre-specified statistical stopping rules to guide these interim analyses.